Diagnostics and therapeutics for diseases associated with g-protein coupled receptor prostaglandin e2 ep4 (prostaglandin e2 ep4)

作者: Stefan Golz , Andreas Geerts , Ulf Brüggemeier

DOI:

关键词: Urological DiseasesImmunologyHematological DiseasesProstaglandin E2MedicinePharmacologyCancerG protein-coupled receptorDermatological diseases

摘要: The invention provides a human prostaglandin E2 EP4 which is associated with the cardiovascular diseases, urological hematological endocrinological dermatological gastroenterological metabolic respiratory diseases and cancer. also assays for identification of compounds useful in treatment or prevention features bind to and/or activate inhibit activity as well pharmaceutical compositions comprising such compounds.

参考文章(35)
Brenda W. Griffin, Najam A. Sharif, Peter G. Klimko, Prostaglandin E agonists for treatment of glaucoma ,(1999)
Kathleen M. Metters, Mervyn Turner, Francois J. Nantel, Theodore P. Broten, Method of treating or preventing urinary incontinence using prostanoid ep1 receptor antagonists ,(2001)
M. Negishi, Y. Sugimoto, A. Irie, S. Narumiya, A. Ichikawa, Two isoforms of prostaglandin E receptor EP3 subtype : different cooh-terminal domains determine sensitivity to agonist-induced desensitization Journal of Biological Chemistry. ,vol. 268, pp. 9517- 9521 ,(1993) , 10.1016/S0021-9258(18)98381-X
Marc Labelle, Gideon Rodan, Mohamed Machwate, Kathleen Metters, Shun-ichi Harada, Miron Weinreb, Robert Young, Methods for stimulating bone formation ,(1999)
John W. Regan, Daniel W. Gil, Human EP3 prostaglandin receptor ,(2000)
Marc Labelle, Michel Belley, Laird A. Trimble, Michel Gallant, Nathalie Chauret, Nicholas Lachance, Chun Li, Prostaglandin receptor ligands ,(1999)